Q: Where did you go to college/graduate school?
I completed a bachelor’s in biomedical sciences with a minor in public health from the University of South Florida
…
SPONSORED CONTENT
TIP: Covered entities must protect their 340B programs from manufacturers attempting to reduce savings and eligibility.
SPONSORED CONTENT
Please join on us October 8th at 2pm EST for our second installment of RxParadigm’s 340B Clearinghouse Webinar Series.
As the 340B landscape continues to shift, it is time for action to deliver consistency and sustainability and a 340B future that
…
SPONSORED CONTENT
The Affordable Care Act (ACA) was enacted in 2010 to make comprehensive health insurance coverage available to more Americans and support innovative clinical delivery methods created to lower the cost of care. Each year, the program hosts an open enrollment
…
SPONSORED CONTENT
You cannot predict when an audit will happen. But you can prepare.
If you operate a 340B covered entity (CE), you know HRSA will eventually come to review your 340B program compliance and integrity. But when?
HRSA’s
…
Q: Tell us some interesting details about your company’s history.
Equiscript, founded in 2009 in Charleston, SC, provides tools and services that improve patient access to medications and health outcomes.
…
SPONSORED CONTENT
Being part of the 340B program is not just about saving money; it also requires careful management of those savings. To get the most out of the 340B program, organizations should accurately calculate savings and carefully manage and document how they are used.
…SPONSORED CONTENT
Artificial Intelligence (AI) is making significant strides in healthcare, and its potential impact on the 340B Drug Pricing Program is becoming increasingly evident.
AI offers innovative solutions that could streamline
… SPONSORED CONTENT
TIP: Understand your patient population and workflows to get the most out of 340B.
To maximize your
SPONSORED CONTENT
Join Ravin Consultants for an insightful webinar on the ever-changing 340B landscape. We will explore the latest contract pharmacy restrictions and state responses as well as mitigation strategies and alternative distribution models. In addition to getting an update on the latest developments from
…*Sign up for news summaries and alerts from 340B Report
